Harrow, Inc. (HROW)
52.40
+0.85
(+1.65%)
USD |
NASDAQ |
Feb 24, 13:15
Harrow EPS Diluted (Quarterly) : 0.0262 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Assertio Holdings, Inc. | 1.612 |
| CapsoVision, Inc. | -0.1693 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.02M |
| Revenue (Quarterly) | 71.64M |
| Total Expenses (Quarterly) | 70.62M |
| Enterprise Value | 2.087B |
| Gross Profit Margin (Quarterly) | 75.28% |
| Profit Margin (Quarterly) | 1.42% |
| Earnings Yield | -0.29% |
| Operating Earnings Yield | 1.43% |
| Normalized Earnings Yield | -0.0147 |